MGTX

MeiraGTx Holdings PLC

Price

$14.02

return (12m)

91.20%

p/e

15.83

p/bv

5.79

DIVIDEND YIELD

0.00%

MGTX price

MeiraGTx Holdings

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MGTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

13.02%

3 months

55.72%

1 year

91.20%

2 years

258.44%

5 years

13.39%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals MGTX

Valuation

P/E

15.83

Sector -4.23

Industry -4.23

P/BV

5.79

Sector 2.11

Industry 2.11

P/Revenue (PSR)

3.14

Sector 2.05

Industry 2.05

EV/EBITDA

Sector -546.75

Industry -546.75

EV/EBIT

Sector -37.85

Industry -37.85

P/EBITDA

Sector -51.33

Industry -51.33

P/EBIT

Sector -39.56

Industry -39.56

P/Total Assets

3.15

Sector 1.25

Industry 1.25

P/Net Current Assets

33.17

Sector -5.36

Industry -5.36

P/Working Capital

7.80

Sector -1.24

Industry -1.24

EPS

0.87

Sector -1.92

Industry -1.92

BVPS

2.37

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

98.20%

Sector 39.10%

Industry 39.10%

EBITDA Margin

0.00%

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

0.00%

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

46.30%

Sector -36.62%

Industry -36.62%

Net Profit Margins

19.86%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.81

Sector 0.03

Industry 0.03

Profitability

ROE

36.58%

Sector -60.49%

Industry -60.49%

ROA

19.91%

Sector -63.06%

Industry -63.06%

ROIC

0.00%

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

3.76

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.46

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

0.46

Sector -0.83

Industry -0.83

Equity/Assets

0.54

Sector 0.43

Industry 0.43

Liabilities/Assets

0.46

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

60.18%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals MGTX

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF MeiraGTx Holdings ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$14.02

Fair Value

$6.81

Upside Return potential.

-51.40%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MGTX MeiraGTx Holdings PLC	$14.02	91.99%	0.00%	15.83	5.79	36.58%	19.86%
JNJ Johnson & Johnson	$277.82	60.73%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.67	22.83%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$260.84	27.01%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-12.95%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$151.13	83.70%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$164.27	2.46%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.65	49.46%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$75.60	-49.60%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$443.34	60.06%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$841.88	49.91%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.11	50.14%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$920.40	33.76%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$557.35	38.99%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$247.26	67.44%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$42.74	15.20%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,061.23	50.23%	0.00%	3.11	3.48	112.18%	44.41%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MGTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT MeiraGTx Holdings

MeiraGTx Holdings PLC

Average Investor10 user rating

4.0 (0 people)

United States

8 years

Founded: 2018

2018

Time since IPO - 8 years

219

Employees

MeiraGTx Holdings PLC (United States) is listed on the Nasdaq and has a market capitalization of $1.25 billion, with shareholders equity totaling $215.78 million.

The company employs approximately 219 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, MeiraGTx Holdings PLC reported $397.49 million in revenue, generating net income of $78.94 million.

Key financial metrics include a P/E ratio of 15.83, a price-to-book (P/B) ratio of 5.79, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MGTX.

Market cap

$1.25 billion

Net worth

$215.78 million

$215,780,000.00

Assets

$396.45 million

$396,450,000.00

Total Shares Outstanding

91.00 million

91,000,000

Average Daily Trading Volume

$891.28 Thousand

$891,281.30

Sector

Health Care

Industry

Biotechnology

MGTX

MGTX revenue and profits

Financial Results MGTX

DRAG THE FRAME TO SEE MORE DATA

MGTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$920.40 33,91% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$247.26 66,32% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$260.84 27,05% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$151.13 86,53% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$164.27 2,98% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.67 23,78% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$920.40 33,91% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$247.26 66,32% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$260.84 27,05% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$151.13 86,53% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$164.27 2,98% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.67 23,78% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of MeiraGTx Holdings (MGTX) today?

A cotação de MeiraGTx Holdings (MGTX) hoje está em US$ 14.02, com uma variação de 91.2% em relação ao último ano. A cotação de MeiraGTx Holdings (MGTX) iniciou o ano negociando na casa dos US$ 7.95 e hoje está em US$ 14.02. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de MeiraGTx Holdings (MGTX) e dados de ações do Ibovespa e mercados internacionais.

Quando MeiraGTx Holdings (MGTX) paga dividendos?

MeiraGTx Holdings (MGTX) não distribuiu dividendos no último ano.

Is MeiraGTx Holdings (MGTX) a good investment?

Atualmente, MeiraGTx Holdings (MGTX) está cotada a US$ 14.02, com um P/L de 15.83, representando um desvio de -9% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 91.2 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 91.20%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy MeiraGTx Holdings (MGTX) stock?

Investir em ações de MeiraGTx Holdings (MGTX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of MeiraGTx Holdings (MGTX) yield today?

A rentabilidade de MeiraGTx Holdings (MGTX) foi de 13.02% no último mês, 91.20% no último ano e 13.39% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de MeiraGTx Holdings (MGTX) hoje, o investimento total seria de US$ 1,401.50, com base na cotação atual de US$ 14.02.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,679.67
Em 5 anos: US$ 1,589.16
Em 10 anos: US$ 1,401.50

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MGTX

MeiraGTx Holdings PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MGTX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING MGTX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT MeiraGTx Holdings

MeiraGTx Holdings PLC

United States

8 years

2018

219

PROFIT X PRICE MGTX

Financial Results MGTX

MGTX cash flow

Asset, Revenue and Profit Growth - MGTX

MGTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions